Skip to main content
SpringerLink
Log in

Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

In order to investigate the behavioural effect of selective blockade of M1 muscarinic receptors in the forebrain, and to characterize a new model for the evaluation of muscarinic agonistic activity, the effect of intrastriatally injected pirenzepine was studied in mice. The direct injection of pirenzepine (0.01–1 μg/mouse) into the right striatum of conscious mice resulted in contralateral turning behaviour. When injected intraperitoneally (IP) 15 min before pirenzepine (1 μg), the muscarinic receptor agonists arecoline and pilocarpine (0.3–3 mg/kg), oxotremorine (0.003–0.03 mg/kg) and RS 86 (0.03–1 mg/kg) antagonized pirenzepine-induced turning, as did the choline-esterase inhibitor physostigmine (0.01–0.1 mg/kg) and the nootropic drug aniracetam (10–30 mg/kg). Haloperidol (0.03–0.3 mg/kg IP) weakly, but significantly, decreased the effect of pirenzepine, whereas (±) sulpiride (3–100 mg/kg) failed to affect it. Finally, (+)-amphetamine (0.1–3 mg/kg IP), citalopram (1–30 mg/kg IP) and muscimol (0.03–0.3 mg/kg IP) failed to modify pirenzepine-induced turning when administered prior to intrastriatal pirenzepine.

These results suggest an involvement of M1 muscarinic receptors in rotational behaviour, and indicate that pirenzepine-induced turning may represent a new model for studying the central activity of cholinomimetic drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Biziere K, Gueudet C, Worms P (1986) Further evidence for a cholinomimetic activity of minaprine. Br J Pharmacol 87 Suppl:31 P

  • Butcher LL (1977) Nature and mechanisms of cholinergic-monoaminergic interactions in the brain. Life Sci 21:1207–1226

    Google Scholar 

  • Carmine AA, Brogden RN (1985) Pirenzepine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer and other allied diseases. Drugs 30:85–126

    Google Scholar 

  • Chambers LK, Van Hartesveldt C (1984) Effects of intrastriatal and intracortical scopolamine on behaviour in rats. Pharmacol Biochem Behav 21:471–473

    Google Scholar 

  • Christensen AV, Fjalland B, Pedersen V, Samsoe PD, Svendsen O (1977) Pharmacology of a new phtalane (Lu 10–171) with specific 5-HT uptake inhibiting properties. Eur J Pharmacol 41:153–162

    Google Scholar 

  • Costall B, Naylor RJ (1974) Specific asymetric behaviour induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms. Naunyn Schmiedeberg's Arch Pharmacol 285:83–91

    Google Scholar 

  • Costall B, Naylor RJ, Olley JE (1972) Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology 11:645–663

    Google Scholar 

  • Cumin R, Bandle EF, Gamzu E, Haefely WE (1982) Effects of a novel compound aniracetam (RO 13–5057) upon impaired learning and memory in rodents. Psychopharmacology 78:104–111

    Google Scholar 

  • Fjalland B, Moller-Nielsen I (1974) Methylphenidate antagonism of haloperidol, interaction with cholinergic and anticholinergic drugs. Psychopharmacologia 34:111–118

    Google Scholar 

  • Fuenmayor LD, Vogt M (1979) The influence of cerebral serotonin on catalepsy induced by brain amine depleting neuroleptics or by cholinomimetics. Br J Pharmacol 67:309–318

    Google Scholar 

  • Giachetti A, Micheletti R, Montagna E (1986) Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist. Life Sci 38:1663–1672

    Google Scholar 

  • Gonzalez LP, Ellinwood EH Jr (1984) Cholinergic modulation of stimulant-induced behavior. Pharmacol Biochem Behav 20:397–403

    Google Scholar 

  • Hammer R, Giachetti A (1982) Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci 31:2991–2998

    Google Scholar 

  • Hammer R, Berrie CP, Birdsall NJM, Burgen ASV, Hulme EC (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283:90–92

    Google Scholar 

  • Hoss W, Messer W Jr (1986) Multiple muscarinic receptors in the CNS. Significance and prospects for future research. Biochem Pharmacol 35:3895–3901

    Google Scholar 

  • Kelly PH, Miller RJ (1975) The interaction of neuroleptic and muscarinic agents with central dopaminergic systems. Br J Pharmacol 54:115–121

    Google Scholar 

  • Klemm WR (1985) Evidence for a cholinergic role in haloperidol-induced catalepsy. Psychopharmacology 85:139–142

    Google Scholar 

  • Krogsgaard-Larsen P, Johnston GAR, Curtis DR, Game CJ, Mc Cullough RM (1975) Structure and biological activity of a series of conformationally restricted analogues of GABA. J Neurochem 25:803–809

    Google Scholar 

  • Lehmann J, Langer SZ (1982) Muscarinic receptors on dopamine terminals in the cat caudate nucleus: neuromodulation of 3H-dopamine release in vitro by endogenous acetylcholine. Brain Res 248:61–67

    Google Scholar 

  • Lloyd KG (1978) Neurotransmitter interactions related to central dopamine neurons. In: Youdim MBH, Lovenberg W, Sharman DF, Lagnado JR (eds) Essays in neurochemistry and neuropharmacology. Wiley, Chichester, pp 131–207

    Google Scholar 

  • Marchi M, Paudice P, Bonanno G, Raiteri M (1985) Presynaptic muscarinic receptor activation enhances striatal dopamine release evoked by depolarization but not that induced by non-depolarizing stimuli. Neurochem Int 7:137–141

    Google Scholar 

  • Matthews RT, Chiou CY (1979) Effects of acute and chronic injections of carbachol in the rat caudate nucleus. Neuropharmacology 18:291–294

    Google Scholar 

  • McKenzie GM, Gordon RJ, Viik K (1972) Some biochemical and behavioural correlates of a possible animal model of human hyperkinetic syndromes. Brain Res 47:439–456

    Google Scholar 

  • Palacios JM, Bolliger G, Closse AM, Enz A, Gmelin G, Malanowski J (1986) The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-4,5-decan-1,3-dion hydrobromide). A potent specific muscarinic acetylcholine receptor agonist. Eur J Pharmacol 125:45–62

    Google Scholar 

  • Pedata F, Moroni F, Pepeu GC (1984) Effect of nootropic agents on brain cholinergic mechanisms. Clin Neuropharmacol 7 (Suppl 1):772–773

    Google Scholar 

  • Pycock CJ (1980) Turning behaviour in animals. Neuroscience 5:461–514

    Google Scholar 

  • Pycock CJ, Milson J, Tarsy D, Marsden CD (1978) The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system. Neuropharmacology 17:175–183

    Google Scholar 

  • Raiteri M, Leardi R, Marchi M (1984) Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J Pharmacol Exp Ther 228:209–215

    Google Scholar 

  • Resul B, Lewander T, Ringdahl B, Zetterstrom T, Dahlbom R (1982) The pharmacological assessment of a new potent oxotremorine analogue in mice and rats. Eur J Pharmacol 80:209–215

    Google Scholar 

  • Ringdahl B, Jenden DJ (1983) Pharmacological properties of oxotremorine and its analogs. Life Sci 32:2401–2413

    Google Scholar 

  • Russel RW, Smith CA, Booth RA, Jenden DJ, Waite JR (1986) Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123). Psychopharmacology 90:308–315

    Google Scholar 

  • Schoffelmeer ANM, Van Vliet BJ, Wardeh G, Mulder AH (1986) Muscarine receptor-mediated modulation of (3H) dopamine and (14C) acetylcholine release from rat neostriatal slices: selective antagonism by gallamine, but not pirenzepine. Eur J Pharmacol 128:291–294

    Google Scholar 

  • Sethy VH (1983) Effect of piracetam on high affinity choline uptake. Soc Neurosci Abstr 9:429

    Google Scholar 

  • Shih YH, Pugsley TA (1985) The effects of various cognition-enhancing drugs on in vitro rat hippocampal synaptosomal sodium dependent high affinity choline uptake. Life Sci 36:2145–2152

    Google Scholar 

  • Vickroy TW, Watson M, Yamamura HI, Roeske WR (1984) Agonist binding to multiple muscarinic receptors. Fed Proc 43:2785–2790

    Google Scholar 

  • Wamsley JK, Gehlert DR, Roeske WE, Yamamura HI (1984) Muscarinic antagonist binding sites heterogeneity as evidenced by autoradiography after direct labelling with (3H) QNB and (3H) pirenzepine. Life Sci 34:1395–1402

    Google Scholar 

  • Watson M, Vickroy TW, Roeske WR, Yamamura HI (1983) Subclassification of muscarinic receptors based upon the selective antagonist pirenzepine. TIPS Suppl:9–11

  • Worms P, Depoortere H, Lloyd KG (1979) Neuropharmacological spectrum of muscimol. Life Sci 25:607–614

    Google Scholar 

  • Worms P, Gueudet C, Biziere K (1986) Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: Pharmacological analysis of a simple screening model. Life Sci 39:2199–2208

    Google Scholar 

  • Worms P, Chambon JP, Biziere K (1987) Behavioural evidence for a selective GABA A antagonistic activity of SR 95103 and SR 42641 after intrastriatal injection in mice. Eur J Pharmacol 138:343–350

    Google Scholar 

  • Zetler G (1968) Cataleptic state and hypothermia in mice caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugs. Int J Neuropharm 7:325–335

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurobiology, Sanofi Recherche, Rue du Pr. J. Blayac, F-34082, Montpellier, France

    P. Worms & K. Biziere

Authors
  1. P. Worms
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Biziere
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Worms, P., Biziere, K. Antagonism by cholinomimetic drugs of the turning induced by intrastriatal pirenzepine in mice. Psychopharmacology 93, 489–493 (1987). https://doi.org/10.1007/BF00207240

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00207240

Key words

Search

Navigation